Pneumonia Research Today is a free monthly online journal that collates and summarizes the latest research about Pneumonia, including details on symptoms, viral, bacterial, treatment, causes, walking pneumonia.

Volume 2 (2005), Issue 3 (March)

1. Treatment of parainfluenza virus 3 pneumonia in a cardiac transplant recipient with intravenous ribavirin and methylprednisolone.
   J Heart Lung Transplant, 24(3): 343-6. [Abstract] [Full-text]
2. Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital.
   Int J Antimicrob Agents, 25(3): 260-3. [Abstract] [Full-text]
3. Imaging in immunocompetent children who have pneumonia.
   Radiol Clin North Am, 43(2): 253-65. [Abstract] [Full-text]
4. Effects of orientation, intermittent rest and vehicle cleaning during transport on development of transport-related respiratory disease in horses.
   J Comp Pathol, 132(2): 153-68. [Abstract] [Full-text]
5. Pneumonia in nursing home residents: factors associated with in-home care of EverCare enrollees.
   J Am Geriatr Soc, 53(3): 472-7. [Abstract] [Full-text]
6. Reversible and irreversible airway inflammation and fibrosis in mice exposed to inhaled ovalbumin.
   Inflamm Res, 54(2): 57-65. [Abstract] [Full-text]
7. Late anthracyclines cardiotoxicity associated with infection by Mycoplasma pneumoniae. A case report.
   Int J Cardiol, 99(2): 351-3. [Abstract] [Full-text]
8. Strategic targets of essential host-pathogen interactions.
   Respiration, 72(1): 9-25. [Abstract] [Full-text]
9. Rapidly progressive lung disease in a patient with cystic fibrosis on long-term azithromycin: possible role of mycoplasma infection.
   J Cyst Fibros, 4(1): 71-3. [Abstract] [Full-text]
10. A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense.
    Am J Respir Crit Care Med, 171(6): 606-15. [Abstract] [Full-text]
11. Surfactant alterations in acute inflammatory lung injury from aspiration of acid and gastric particulates.
    Am J Physiol Lung Cell Mol Physiol, 288(4): L699-708. [Abstract] [Full-text]
12. Pulmonary inflammation induced by high-stretch ventilation is mediated by tumor necrosis factor signaling in mice.
    Am J Physiol Lung Cell Mol Physiol, 288(4): L599-607. [Abstract] [Full-text]
13. Respiratory viruses in the pediatric intensive care unit: prevalence and clinical aspects.
    Mem Inst Oswaldo Cruz, 99(8): 883-7. [Abstract] [Full-text]
14. Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia.
    Clin Microbiol Infect, 11(4): 319-25. [Abstract] [Full-text]
15. Acute pulmonary inflammation induced by lung overloading with selenium particles: leukocyte response and in situ detection of selenium at high resolution.
    Inhal Toxicol, 16(14): 901-9. [Abstract] [Full-text]
16. The effect of malnutrition on risk and outcome of community-acquired pneumonia.
    Respir Care Clin N Am, 11(1): 99-108. [Abstract] [Full-text]
17. What have we learned about how to measure quality of care for patients with community-acquired pneumonia?
    Respir Care Clin N Am, 11(1): 87-98. [Abstract] [Full-text]
18. The utility of administrative data in helping the clinician understand and treat community-acquired pneumonia.
    Respir Care Clin N Am, 11(1): 67-86. [Abstract] [Full-text]
19. Multicenter, multinational observational studies: a new approach to studying community-acquired pneumonia.
    Respir Care Clin N Am, 11(1): 35-44. [Abstract] [Full-text]
20. Tuberculosis: still overlooked as a cause of community-acquired pneumonia--how not to miss it.
    Respir Care Clin N Am, 11(1): 25-34. [Abstract] [Full-text]
21. Management of community-acquired pneumonia in the emergency room.
    Respir Care Clin N Am, 11(1): 15-24. [Abstract] [Full-text]
22. Do guidelines guide pneumonia practice? A systematic review of interventions and barriers to best practice in the management of community-acquired pneumonia.
    Respir Care Clin N Am, 11(1): 1-13. [Abstract] [Full-text]
23. Human leukocyte antigen-DR expression on peripheral blood monocytes and the risk of pneumonia in pediatric lung transplant recipients.
    Transpl Infect Dis, 6(4): 147-55. [Abstract] [Full-text]
24. Blood culture and susceptibility results and allergy history do not influence fluoroquinolone use in the treatment of community-acquired pneumonia.
    Pharmacotherapy, 25(1): 59-66. [Abstract] [Full-text]
25. Quantitative TaqMan PCR for detection of Pneumocystis jiroveci.
    J Microbiol Methods, 61(3): 381-7. [Abstract] [Full-text]
26. Nuclear bilateral Bell's palsy and ageusia associated with Mycoplasma pneumoniae pulmonary infection.
    J Med Microbiol, 54: 417-9. [Abstract] [Full-text]
27. Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study.
    J Med Microbiol, 54: 395-400. [Abstract] [Full-text]
28. An early thoracoscopic approach in necrotizing pneumonia in children: a report of three cases.
    J Laparoendosc Adv Surg Tech A, 15(1): 18-22. [Abstract] [Full-text]
29. Virulence role of group B Streptococcus beta-hemolysin/cytolysin in a neonatal rabbit model of early-onset pulmonary infection.
    J Infect Dis, 191(8): 1287-91. [Abstract] [Full-text]
30. Uruburuella suis gen. nov., sp. nov., isolated from clinical specimens of pigs.
    Int J Syst Evol Microbiol, 55: 643-7. [Abstract] [Full-text]
31. Role of beta-lactam agents in the treatment of community-acquired pneumonia.
    Eur J Clin Microbiol Infect Dis, 24(2): 83-99. [Abstract] [Full-text]
32. Selection of predictor variables for pneumonia using neural networks and genetic algorithms.
    Methods Inf Med, 44(1): 89-97. [Abstract] [Full-text]
33. Expression of secretory phospholipase A2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells.
    Biochem J, 387: 27-38. [Abstract] [Full-text]
34. The efficacy of fluorocarbon, surfactant, and their combination for improving acute lung injury induced by intratracheal acidified infant formula.
    Anesth Analg, 100(4): 964-71. [Abstract] [Full-text]
35. Mucosal immunisation with novel Streptococcus pneumoniae protein antigens enhances bacterial clearance in an acute mouse lung infection model.
    FEMS Immunol Med Microbiol, 44(1): 59-67. [Abstract] [Full-text]
36. Fusobacteriosis presenting as community acquired pneumonia.
    J Infect, 50(3): 236-9. [Abstract] [Full-text]
37. An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model.
    J Gen Virol, 86: 991-1000. [Abstract] [Full-text]
38. Q fever pneumonia: virulence of Coxiella burnetii pathovars in a murine model of aerosol infection.
    Infect Immun, 73(4): 2469-77. [Abstract] [Full-text]
39. Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals.
    Infect Immun, 73(4): 2083-93. [Abstract] [Full-text]
40. Acute inflammatory responses to Stachybotrys chartarum in the lungs of infant rats: time course and possible mechanisms.
    Toxicol Sci, 84(2): 408-17. [Abstract] [Full-text]
41. Inverse association between Chlamydia pneumoniae respiratory tract infection and initiation of asthma or allergic rhinitis in children.
    Pediatr Allergy Immunol, 16(2): 137-44. [Abstract] [Full-text]
42. Antibiotic prophylaxis of early onset pneumonia in critically ill comatose patients. A randomized study.
    Intensive Care Med, 31(4): 510-6. [Abstract] [Full-text]
43. Prospective study of neutrophil chemokine responses in trauma patients at risk for pneumonia.
    Am J Respir Crit Care Med, 171(7): 753-9. [Abstract] [Full-text]
44. Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection.
    Antimicrob Agents Chemother, 49(4): 1337-9. [Abstract] [Full-text]
45. Activity of Hoechst 33258 against Pneumocystis carinii f. sp. muris, Candida albicans, and Candida dubliniensis.
    Antimicrob Agents Chemother, 49(4): 1326-30. [Abstract] [Full-text]
46. Early tracheostomy versus late tracheostomy in the surgical intensive care unit.
    Am J Surg, 189(3): 293-6. [Abstract] [Full-text]
47. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.
    Lancet, 365(9465): 1139-46. [Abstract] [Full-text]
48. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis.
    Am J Infect Control, 33(3): 157-61. [Abstract] [Full-text]
49. Withholding or starting antibiotic treatment in patients with dementia and pneumonia: prediction of mortality with physicians' judgment of illness severity and with specific prognostic models.
    Med Decis Making, 25(2): 210-21. [Abstract] [Full-text]

© 2004-2008 Pneumonia Research Today. All Rights Reserved.